Hillman Cancer Center at University of Pittsburgh Cancer Institute

Pittsburgh, Pennsylvania 15236

0 studies enrolling now · 52 studies all time

What they study most

Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Cachexia, Carcinoma of Unknown Primary, Chronic Myeloproliferative Disorders, Colorectal Cancer, Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Glioblastoma, Glioma, Malignant

Studies at this site

• GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas — Completed
• BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations — Completed
• Microtubule-Targeted Agent BAL101553 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma — Stopped early
• Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes — Completed
• Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas — Stopped early
• Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18) — Completed
• Terameprocol in Treating Patients With Recurrent High Grade Glioma — Completed
• Daunorubicin & Cytarabine +/- Zosuquidar inTreating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or Refractory Anemia — Completed
• Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer — Completed
• Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia — Completed
• Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer — Completed
• S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer — Completed
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer — Completed
• Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ — Completed
• HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma — Completed
• Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 — Completed
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer — Completed
• Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma — Completed
• Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
• Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma — Stopped early
• Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma — Completed
• Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor — Completed
• Imatinib Mesylate in Treating Patients With Recurrent Malignant Glioma or Meningioma — Completed
• Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma — Completed
• Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors — Completed
• CCI-779 in Treating Patients With Malignant Glioma — Completed
• Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma — Completed
• Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer — Completed
• Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function — Completed
• Combination Chemotherapy in Treating Patients With Bladder Cancer — Completed
• Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer — Completed
• Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions — Completed
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery — Completed
• Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer — Completed
• Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women — Completed
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma — Completed
• Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer — Stopped early
• Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia — Completed
• Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma — Completed
• Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme — Completed
• Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver — Status unconfirmed
• Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer — Completed
• Fludarabine Combined With Either Alemtuzumab or Rituximab in Treating Patients With Refractory or Relapsed B-Cell Chronic Lymphocytic Leukemia — Completed
• Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Withdrawn before enrolling
• S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer — Completed
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer — Completed
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy — Completed
• Bortezomib, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Stomach Cancer — Stopped early
• Combretastatin A4 Phosphate in Treating Patients With Advanced Anaplastic Thyroid Cancer — Completed